Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:34 PM
Ignite Modification Date: 2025-12-25 @ 2:26 PM
NCT ID: NCT04396366
Description: None
Frequency Threshold: 5
Time Frame: Adverse events were reported from first dose of study treatment until end of study treatment plus 30 days post-treatment, up to a maximum duration of 114 days.
Study: NCT04396366
Study Brief: Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
QBW251 300 mg b.i.d Participants received QBW251 300 mg orally, twice daily (b.i.d.), for 12 weeks. 0 None 2 21 14 21 View
Placebo Participants received matching placebo, b.i.d., for 12 weeks. 0 None 0 21 13 21 View
Total Total 0 None 2 42 27 42 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Infective exacerbation of bronchiectasis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (25.1) View
Tubulointerstitial nephritis SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA (25.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Fatigue SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Peripheral swelling SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA (25.1) View
COVID-19 SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (25.1) View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (25.1) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (25.1) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (25.1) View
Bronchiectasis SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Oropharyngeal pain SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Rhinorrhoea SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA (25.1) View
Gastrooesophageal reflux disease SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (25.1) View